ES2245505T3 - Metodos y composiciones para la sintesis de peptidos (t-20). - Google Patents

Metodos y composiciones para la sintesis de peptidos (t-20).

Info

Publication number
ES2245505T3
ES2245505T3 ES99912802T ES99912802T ES2245505T3 ES 2245505 T3 ES2245505 T3 ES 2245505T3 ES 99912802 T ES99912802 T ES 99912802T ES 99912802 T ES99912802 T ES 99912802T ES 2245505 T3 ES2245505 T3 ES 2245505T3
Authority
ES
Spain
Prior art keywords
seq
fmoc
peptide
formula
secondary chains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99912802T
Other languages
English (en)
Spanish (es)
Inventor
Myung-Chol Kang
Brian Bray
Maynard Lichty
Catherine Mader
Gene Merutka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trimeris Inc
Original Assignee
Trimeris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/045,920 external-priority patent/US6281331B1/en
Application filed by Trimeris Inc filed Critical Trimeris Inc
Application granted granted Critical
Publication of ES2245505T3 publication Critical patent/ES2245505T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES99912802T 1998-03-23 1999-03-22 Metodos y composiciones para la sintesis de peptidos (t-20). Expired - Lifetime ES2245505T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/045,920 US6281331B1 (en) 1998-03-23 1998-03-23 Methods and compositions for peptide synthesis
US45920 1998-03-23
US09/071,877 US6015881A (en) 1998-03-23 1998-05-01 Methods and compositions for peptide synthesis
US71877 1998-05-01

Publications (1)

Publication Number Publication Date
ES2245505T3 true ES2245505T3 (es) 2006-01-01

Family

ID=26723345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99912802T Expired - Lifetime ES2245505T3 (es) 1998-03-23 1999-03-22 Metodos y composiciones para la sintesis de peptidos (t-20).

Country Status (13)

Country Link
EP (1) EP1071442B9 (enExample)
JP (1) JP4602547B2 (enExample)
CN (1) CN100383158C (enExample)
AT (1) ATE299029T1 (enExample)
AU (1) AU751358B2 (enExample)
BR (1) BR9909018A (enExample)
CA (1) CA2324348C (enExample)
DE (1) DE69926061T2 (enExample)
DK (1) DK1071442T3 (enExample)
ES (1) ES2245505T3 (enExample)
NZ (1) NZ507083A (enExample)
TW (1) TWI233931B (enExample)
WO (1) WO1999048513A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
ES2525317T3 (es) 2001-06-15 2014-12-22 F. Hoffmann-La Roche Ag Producción recombinante de inhibidores de la fusión antivirales peptídicos
AU2003257467B2 (en) * 2002-07-24 2008-02-28 F. Hoffmann-La Roche Ag Pegylated T20 polypeptide
DE602004017057D1 (de) 2003-12-31 2008-11-20 Hoffmann La Roche Verfahren und systeme zur rückgewinnung von peptiden
EP1701976A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Peptide synthesis and deprotection with co-solvent
EP1701969B1 (en) 2003-12-31 2007-10-24 F.Hoffmann-La Roche Ag Process for peptide synthesis using a reduced amount of deprotection agent
CA2592438C (en) * 2004-12-30 2013-09-03 F.Hoffmann-La Roche Ag Synthesis of peptide t-20 using peptide intermediate fragments
CA2651070A1 (en) 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
WO2009014177A1 (ja) * 2007-07-25 2009-01-29 Ajinomoto Co., Inc. ジベンゾフルベン誘導体の淘汰方法
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
AU2008334783A1 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
EP2322498B1 (en) * 2008-08-06 2014-04-16 Ajinomoto Co., Inc. Processes for removing dibenzofulvene
US20110288235A1 (en) * 2008-09-03 2011-11-24 Scinopharm Taiwan Ltd. Process for the Preparation of Pramlintide
AU2009288036A1 (en) * 2008-09-03 2010-03-11 Scinopharm Taiwan, Ltd. Process for the preparation of pramlintide
WO2011095989A2 (en) * 2010-02-04 2011-08-11 Matrix Laboratories Ltd An improved process for the preparation of enfuvirtide
PL219569B1 (pl) * 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
CN103374054B (zh) * 2012-04-28 2014-12-24 上海第一生化药业有限公司 一步法固相合成多肽的方法
GB201315335D0 (en) 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
CA3167047A1 (en) * 2020-02-05 2021-08-12 Martin D. Johnson Three resin reactors in series peptide synthesizer
CN114315957B (zh) * 2021-12-30 2023-07-07 深圳瑞德林生物技术有限公司 一种多肽的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007616A1 (en) * 1986-06-12 1987-12-17 Biogen N.V. Peptides involved in the pathogenesis of hiv infection
US4787222A (en) * 1986-11-24 1988-11-29 Novatek Medical Inc. Combination lock for blood identification system
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
EP0708659A4 (en) * 1993-06-07 2000-08-23 Genentech Inc HIV ENVELOPE POLYPEPTIDE
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
JPH09502348A (ja) * 1993-09-11 1997-03-11 ポリムン・シエンティフィーク・イムノビオロギッシェ・フォルシュング・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 遺伝学的に分岐したhiv−1株に対する中和抗体を誘導するペプチド
AU722895B2 (en) * 1996-02-09 2000-08-10 F. Hoffmann-La Roche Ag Synthesis of VIP analog

Also Published As

Publication number Publication date
AU751358B2 (en) 2002-08-15
NZ507083A (en) 2003-10-31
CN100383158C (zh) 2008-04-23
TWI233931B (en) 2005-06-11
AU3109799A (en) 1999-10-18
ATE299029T1 (de) 2005-07-15
WO1999048513A1 (en) 1999-09-30
JP4602547B2 (ja) 2010-12-22
JP2002507576A (ja) 2002-03-12
DK1071442T3 (da) 2005-10-24
CN1303299A (zh) 2001-07-11
EP1071442A4 (en) 2002-06-05
EP1071442B1 (en) 2005-07-06
DE69926061T2 (de) 2006-06-01
EP1071442B9 (en) 2006-01-18
CA2324348A1 (en) 1999-09-30
EP1071442A1 (en) 2001-01-31
DE69926061D1 (de) 2005-08-11
CA2324348C (en) 2006-03-14
BR9909018A (pt) 2001-10-16

Similar Documents

Publication Publication Date Title
ES2245505T3 (es) Metodos y composiciones para la sintesis de peptidos (t-20).
JP4755713B2 (ja) ペプチド合成のための方法および組成物
ES2236043T3 (es) Metodos y composiciones para la sintesis de peptidos.
DK2421887T3 (en) A process for the preparation of degarelix
ES2295961T3 (es) Proceso para la sintesis peptidica utilizacndo una cantidad reducida de agente de desproteccion.
ES2315729T3 (es) Procedimiento y sistemas para la recuperacion de peptidos.
CN115181158B (zh) Fmoc基团裂解方法
NO148332B (no) Fremgangsmaate ved fremstilling av et peptid.
ES2329270T3 (es) Sintesis del peptido t-1249 utilizando fragmentos intermediarios del ipeptido.
ES2332142T3 (es) Sintesis de peptidos t-20 usando fragmentos peptidicos intermedios.
JP2009535402A (ja) 保護ペプチドを樹脂から放出するための組成物および方法
MXPA00009211A (en) Methods and compositions for peptide synthesis
MX2008013833A (es) Composicion y metodo para la liberacion de peptidos protegidos de una resina.
Jensen Peptide Synthesis